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h o rm o n e  re ce p to r g en e
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Edwin Mariman1, Axel P.N. Themmen2 & Han G. Brunner1
Leydig cell hypoplasia is a rare autosomal recessive condition that interferes with normal 
development of male external genitalia in 46,XY individuals. We have studied two Leydig 
cell hypoplasia patients (siblings born to consanguineous parents), and found them to 
be homozygous for a missense mutation (Ala593Pro) in the sixth transmembrane 
domain of the luteinizing hormone (LH) receptor gene. In vitro expression studies 
showed that this mutated receptor binds human choriogonadotropin with a normal KD, 
but the ligand binding does not result in increased production of cAMP. We conclude 
that a homozygous LH receptor gene mutation underlies the syndrome of autosomal 
recessive congenital Leydig cell hypoplasia in this family. These results have 
implications for the understanding of the development of the male genitalia.
The process that leads to the development of male sex 
characteristics is generally thought to consist of three 
sequential steps1. The first is the establishment of male 
genetic sex by the XY chromosome pattern at conception.
The second involves the induction of male gonadal sex, 
that is testis formation, through the action of SRY (sex 
determining region of the Y chromosome). The third step 
consists of the development of internal and external male 
genitalia, a process which is basically controlled by two 
factors, testosterone and anti-Miillerian hormone (AMH), 
both produced by the fetal testis. The Sertoli cell product,
AMH, prevents the formation of the mullerian duct 
derivatives (fallopian tubes, uterus and the upper part of 
the vagina), whereas the development of the male internal 
and external genitalia is dependent on the Leydig cell 
product, testosterone, which is converted to 
dihydrotestosterone in certain target tissues. Various 
genetic defects in this pathway have been reported, 
supporting the concept of sequential determination of 
male genetic, gonadal and phenotypic sex2.
An important step in this differentiation cascade is the 
development of the Leydig cells. This apparently begins 
independent of stimulation by gonadotropins at 
approximately the same time that the formation of the 
testicular cords occurs3, although the process still occurs 
in cases where testicular cords do not develop4. Leydig cell 
differentiation is crucial for sufficient androgen production 
by the testis. Absence of Leydig cells or insufficient Leydig 
cell differentiation can occur as an autosomal recessive 
condition5"13. The phenotype of inherited Leydig cell 
hypoplasia ranges from extreme forms presenting as 46,XY 
females to milder forms in which males present with 
hypergonadotropic hypogonadism and a micropenis9,10.
Testicular luteinizing hormone (LH) binding was 
decreased or absent in some studies, which could be 
either the cause or the consequence of hypoplasia of 
Leydig cells5,6. Here, we report studies of the LH receptor 
gene in siblings born to consanguineous parents who 
have male pseudohermaphroditism due to Leydig cell 
hypoplasia.
Clinical details
Our study examined two 46,XY siblings who presented 
with female external genitalia, primary amenorrhea, and 
lack ofbreast development. Their parents are first cousins,
Fig. 1 Pedigree of two siblings with male 
pseudohermaphroditism and Leydig cell hypoplasia.
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and there are 14 additional siblings (Fig. 1). Both cases 
had a short blind ending vagina, without uterus or fallopian 
tubes. Serum levels of testosterone and testosterone 
precursors were abnormally low, and did not respond to 
stimulation by hCG. Basal levels of LH were markedly 
increased, but follicle-stimulating hormone (FSH) was 
within the normal range. The gonads were removed, and 
upon histological examination found to be testes with 
normal Sertoli cells, but no mature Leydig cells (Fig. 2).
Homozygous mutation in the LH receptor gene
The LH receptor gene of the two patients with male 
pseudohermaphroditism was studied for the presence of 
mutations by single strand conformational polymorphism 
(SSCP) analysis. We began by studying exon 11 which 
contains the transmembrane and cytoplasmic domains, 
with two sets of primers (see Methodology). Amplification 
with primer set 1 produced a fragment showing abnormal 
migration. This fragment comprises the third extracellular 
loop and the seventh transmembrane segment, as well as 
parts of the sixth transmembrane segment and the 
intracellular tail.
This part of the LH receptor gene was then sequenced 
in the two affected siblings and in two unaffected controls 
with primers la and lb as sequencing primers. A GCC to 
CCC transversion was detected at position 1787 in the 
patients (Fig. 3 a), producing an Ala593Pro substitution 
in the sixth transmembrane domain (Fig. 3 b). The normal
sequence could not be detected, indicating homozygosity 
of the mutated allele. The presence of two copies of the 
LH receptor gene was confirmed by dosage analysis (data 
not shown).
The mutation inactivates signal transduction
The Ala593Pro mutation was constructed invitro, and the 
resulting mutant LH receptor cDNA transiently expressed 
in human embryonic kidney 293 cells. The high affinity 
(meanKD = 0.8 ± 0.15 nM; n=2) binding of [125I] -labelled 
choriogonadotropin (hCG) to partially purified 
membrane preparations was no different from binding to 
membrane preparations from cells transfected with the 
wild type LH receptor cDNA (mean KD = 0.5 ± 0.4 nM; 
n=2) (Fig. 4). The difference in the values of B ^  of the 
different membrane preparations is partly due to 
experimental variation in transfection efficiency (five­
fold less for the mutant LH receptor construct), andpartiy 
to reduced expression of the mutant receptor at the cell 
membrane. The number of mutant or wild-type receptors 
expressed per transfected cell varied between 1,000 and 
3,000, which is similar to the figure found in vivo14. In 
contrast, when hCG-induced cAMP production was 
determined, no hormonal effect was detected for the 
mutated LH receptor, even at very high (1000 ng/ml) hCG 
concentrations (Fig. 4). These results indicate that the 
miss ense Ala593Pro mutation completely abolishes signal 
transduction, probably at the level of coupling to the
a
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Fig. 2 a, Light photomicrographs of seminiferous tubules and interstitium of one of the patients showing hyalinization of 
the basal membrane and normal peritubular myoid cells. In the Interstitium few Leydig cells, with Immature 
characteristics, are found. The seminiferous epithelium contains Sertoli cells, and almost no germ cells, b, light 
photomicrographs of seminiferous tubules and interstitium of control testis with fully developed interstitium and 
spermatogenic epithelium. (Left, 100X; right, 400X. H/E staining).
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stimulatory GTP-binding protein G , although changes in
$
post-synthesis receptor transport to the plasma membrane 
cannot be excluded. Ligand binding is less likely to be 
affected because this function resides in the N-terminal 
half of the LH receptor molecule15.
Discussion
A homozygous missense mutation in the sixth 
transmembrane domain (Ala593Pro) of the LH receptor 
gene underlies the syndrome of male pseudo­
hermaphroditism due to Leydig cell hypoplasia in our 
family. When the mutant LH receptor gene was transiently 
expressed in HEK29 3 cells, we observed hormone binding 
to the receptor albeit at lower maximal capacity. No 
increase in cAMP occured on stimulation with hCG, even 
at very high hCG concentrations. Therefore, this mutation 
precludes the normal increase in cAMP in response to 
LH/hCG, which renders the mutant receptor non­
functional.
The finding of an LH receptor gene defect as a cause of 
inheritedLeydigcellhypoplasia is consistent with previous 
studies of other patients which have indicated reduced LH 
binding capacity of testicular tissue5,6 and absence of a 
testosterone response to LH5-13. It is likely that a wide 
array of mutations of the LH receptor will be found in 
other families with autosomal recessive forms of male 
pseudoherm aphroditism . Such mutations could 
conceivably affect LH binding, G protein activation, post- 
translational modification or post-synthesis transport, or 
a combination of these processes. In addition, large LH 
receptor gene deletions without any LH receptor mRNA
Fig. 3 LH receptor mutation in patients with 
pseudohermaphroditism, a, DNA Sequence of case 1. A 
G to C homozygous transversion is found at nucleotide 
1787, compared to the normal control, b , Localization of 
the Ala593Pro mutation in the sixth transmembrane 
domain of the LH receptor in the two siblings with male 
pseudohermaphroditism. The localization of two missense 
mutations in families with male-limited precocious 
puberty15-16 are shown for comparison. The right hand 
panel shows the overall structure of the LH receptor with 
seven transmembrane segments, separating three 
intracellular and three extracellular loops.
and protein expression cannot be excluded.
It is likely that milder forms of LH receptor defects 
exist, in which sufficient residual activity is present to 
allow partial masculinization of external genitalia. In 
fact, patients have already been described in whom Leydig 
cell hypoplasia was associated with hypergonadotropic 
hypogonadism, and micropenis, but not hypospadias9,10.
The Ala593Pro mutation abolishes LH receptor 
function in vitro (Fig. 4). This is very different from the 
effect of missense mutations of the LH receptor gene that 
have been found in patients with autosomal dominant 
LH independent male precocious puberty16,17 (Fig 3 b; 
unpublished observations), although they also are located 
near the sixth transmembrane segment. These latter 
mutations — Met571Ile and Asp578Gly — act in a 
dominant fashion by constitutively activating cAMP 
production16 (R.K.), and appear to be subtle: They might 
result in a conformational change that facilitates ligand- 
independent coupling to the G-protein. The Ala593Pro 
mutation, by contrast, might introduce a more drastic 
conformational change in the receptor caused by the 
constrained angle conferred by the proline residue. Such 
mutations are more likely to render the receptor inactive.
Many studies indicate that undifferentiated Leydig 
cells require LH for proliferation and differentiation. In 
humans, fetal Leydig cell number and testosterone 
production correlate with plasma hCG levels18-20. This is 
consistent with experimental studies in rats that have 
shown that full-length LH receptor mRNA is expressed 
in testis from day 16.5 of gestation onwards, suggesting 
an active role for LH/hCG-dependent testosterone 
production in the determination of male external 
genitalia21. After specific removal of differentiated Leydig 
cells from adult rat testes, immature Leydig cells reappear 
more quickly if LH is present22. Furthermore, LH can 
induce morphological differentiation of immature to 
mature Leydig cells in neonatal rats23, and this 
differentiation is parallelled by an increase in the activity 
of the enzymes that are responsible for testicular 
steroidogenesis24.
The initiation of androgen synthesis by Leydig cells 
early in fetal life may be independent of LH or hCG as 
indicated by data from rats and rabbits3,25. Our findings 
may support this notion, because testes with associated 
epididymis and vas deferens were found in both patients. 
These wolffian duct-derived structures can only have 
been formed in the presence of Leydig cell androgens at 
some point in fetal development. Our findings farther 
demonstrate that at a later fetal stage the absence of a 
functional LH receptor interferes with Leydig cell 
proliferation and maturation. In patients with Leydig
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Fig. 4 In vitro studies of mutant and 
wild-type LH receptor gene 
constructs, a, Scatchard plot of the 
mutant receptor (filled circles; 
enlarged in inset) shows reduced 
maximal hormone binding but normal 
affinity, compared to the wild-type 
receptor (open circles). Jb, Right-hand 
panel: hCG-dependent cAMP 
production in wild-type receptor (open 
circles) and mutant receptor (closed 
circles) expressing HEK293 cells. The 
Ala593Pro mutation (LCH) completely 
abolishes hCG dependent cAMP 
production.
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cell hypoplasia, the testes contain normal Sertoli cells, 
with no mature Leydig cells. Sometimes, small clusters of 
immature Leydig cells are present7. The histological 
findings in Leydig cell hypoplasia can now be interpreted 
as reflecting lack of stimulation through the LH receptor.
No abnormal female sex characteristics have been noted 
in sisters of patients with this form of male 
pseudohermaphroditism12, which is consistent with 
experimental results that indicate absence of a functional 
ovarian LH receptor until after birth21. However, LH 
receptor function is required for a normal female menstrual 
cycle. Hence, the presence of primary amenorrhea in a 
46,XX sister of the patients described above shouldbeof 
particular interest. (As this patient lives approximately 
4,000 kilometres from our centre in rural Brazil, we have 
not yet been able to contact the patient and obtain a blood 
sample.) Further studies should reveal if she is indeed 
homozygous for the same LH receptor mis sense mutation. 
Primary amenorrhea with ovarian resistance to luteinizing 
hormone might conceivably be the female counterpart to 
the pattern of male pseudohermaphroditism studied here. 
Amenorrhea has been noted in another sister of a patient 
with pseudohermaphroditism due to Leydig cell 
hypoplasia13.
In conclusion, the finding of an LH receptor defect in 
male pseudohermaphroditism with testicular Leydig cell 
hypoplasia provides a biological basis for this disorder. 
Our data support a crucial role for the LH receptor in 
Leydig cell differentiation, and hence in the regulation of 
embryonal production of testosterone by the male gonad.
Methodology
Patients. The patients are two siblings born to consanguineous first 
cousin parents, The patients originate from a small village in rural 
north/northeast Brazil (Fiaui State). They were referred at ages 37 
and 42, because of primary amenorrhea and lack of breast 
development. Both cases had a eunuchoid habitus, absence of breast 
tissue, and sparse axillary hair. The external genitalia were female 
with distinct urethral and vaginal orifices, and triangle-shaped pubic 
hair. Pelvic ultrasound examination showed no internal genitalia, 
except for the testes which were located in the inguinal region. A 
genitogram demonstrated only the vertical component of the urethra 
and a short blind ending vaginal pouch. The karyotype was 46,XY. 
Baseline testosterone levels were low (0.69 and 0.53 nmol I”1 
respectively; normal 8.3-35.8 nmol l"1). Testosterone precursors 
such as DHEA, 17a-hydroxyprogesterone, progesterone, 
androstenedione, and estradiol were low compared to normal males. 
LH levels were elevated to 23.3 and 19.0 IU I'1; normal 1-8.4 IU l"1). 
FSH and inhibin levels were normal. A stimulation test with hCG 
(6000 IU i.m.) elicited no increase in testosterone levels. The LHRH
test (100 |ig IV) elicited a LH hyperresponse, and normal FSH 
increase. An acute adrenal cortexstimulation test using 1 -24 synthetic 
ACTH (Cortrosyn, Organon, Oss, the Netherlands) did not reveal 
defects in enzymatic steps leading to adrenal androgen synthesis. 
The patients underwent bilateral gonadectomy. Testes were removed 
with normal vasa deferens and epididymides. Histopathological 
examination revealed sem iniferous tubules with thickened 
membranes, few germ cells and a normal number of Sertoli cells. The 
interstitial space contained vascular conjunctive stroma and 
fibroblasts with absence of Leydig cells.
Mutation analysis. Genomic DNA was isolated from peripheral 
blood as described26. Because o ther family m em bers live 
approximately4,000 kilometres from Sao Paulo, only the index cases 
were studied.
DNA fragments were amplified with PCR and analysed by SSCP 
analysis17 with the followingadaptations for primer set I (see below);
1 mM MgCl2 in the PCR and an annealing temperature of 58 *C. Two 
different sets of prim ers were used in the PCR: (la ) 5 '-  
CGATTTCACCTGCATGGC-3' (n t 1731—1748), ( lb )  5’~* 
CCCGACGTTTACAGCAGCC-3' (n t 1924-1942); (2a) 5’-  
TATCCCATCAATTCTTGTGCC-3' (n t 1834-1854), (2b) 5 '-  
GGATTGAGAAGGCTTATTTGATCC-31 (n t 2005-2028). 
Nucleotide numbers are according to Minegishi et a l27
For sequencing, the DNA fragments were separated on a 1.5% 
LMP agarose gel BRL Life Technologies and purified with the gelase 
system (Epicentre Technologies) according to the Kfast protocol” 
given by the manufacturer. About 50 fmol of the purified DNA 
fragments and the la and lb primers were used for sequencing with 
the cycle sequencing kit of BRL (BRL Life technologies).
In  vitro expression. The wild type human LH receptor expression 
plasmid (pSG5-hLHR) was constructed by cloning the human LH 
receptor cDNA (nucleotides -3  to 2374 relative to the translation 
start site) into the EcoRl site of pSG5, an expression vector that 
contains the SV40 large T early promoter, intron II of the rabbit (3- 
globin gene, and an SV40 polyadenylation signal24. The protein 
encoded by this cDNA differs from the published human LH 
receptor27 by the insertion of two amino acids (Leu and Gin) at 
positions 20 and 21 (E.M., unpublished observations). The Ala593Pro 
m utation was constructed in pSG5-hLHR by site-directed 
mutagenesis using PCR29, yielding pSG5-hLHR4. Mutagenesis was 
confirmed by sequence analysis, and revealed an additional nucleotide 
change (C to A) at position 1983 in the pSG5-hLHR4 vector, This 
change does not alter the amino acid encoded by this codon. Human 
embryonic kidney 293 (HEK293) cells were transiendy transfected 
as described before30. 48 h after transfection, [125I]-hCG (Dupont) 
binding to partially purified membranes was determined according 
toKetelslegers&Catt31. For the estimation ofhCG-dependentcAMP 
production, HEK293 cells were co-transfected in 12 well tissue 
culture plates (Costar, Cambridge, MA, USA) with a luciferase 
expression plasmid pRSVluc32 and pSG5, pSG5-hLHR or pSG5- 
hLHR4. 48 h after transfection cells were incubated for 2 h with 
culture medium containing 0,1% BSA and 0.2 mM isobutyl- 
methylxanthine (Sigma) and different concentrationsofhCG (urinary
Genetics volume 9 february 1995 163
hCG; Organon International, Oss> The Netherlands). Mediumwas 
collected and cAMP production determined as described before33,34. 
The remaining cells were lysed, and luciferase activity was 
determined35. The final cAMPproduction in the transfected cells was 
determined by subtraction by the basal cAMP production in pSG5- 
transfected cells, and subsequent correction for transfection efficiency 
using the luciferase activities of the same wells.
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